__NUXT_JSONP__("/drugs/Ceritinib", (function(a,b,c,d,e){return {data:[{drug:{slug:a,emaEpar:[{activeSubstance:b,conditionIndication:"Zykadia is indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK) positive advanced non small cell lung cancer (NSCLC) previously treated with crizotinib.",inn:b,marketingAuthorisationDate:"2015-05-06 00:00:00",marketingAuthorisationHolder:"Novartis Europharm Limited",medicineName:c,url:"https:\u002F\u002Fwww.ema.europa.eu\u002Fen\u002Fmedicines\u002Fhuman\u002FEPAR\u002Fzykadia"}],fdaDrugLabel:[{brand:"ZYKADIA",indication:"1 INDICATIONS AND USAGE ZYKADIA Â® is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test [see Dosage and Administration (2.1)] . ZYKADIA is a kinase inhibitor indicated for the treatment of adults with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test. ( 1 , 2.1 )",manufacturer:"Novartis Pharmaceuticals Corporation",splSetId:"fff5d805-4ffd-4e8e-8e63-6f129697563e"}],id:a,nciThesaurus:{casRegistry:"1032900-25-6",chebiId:d,chemicalFormula:d,definition:"An orally available inhibitor of the receptor tyrosine kinase activity of anaplastic lymphoma kinase (ALK) with antineoplastic activity. Upon administration, ceritinib binds to and inhibits wild-type ALK kinase, ALK fusion proteins and ALK point mutation variants. Inhibition of ALK leads to both the disruption of ALK-mediated signaling and the inhibition of cell growth in ALK-overexpressing tumor cells. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development. ALK dysregulation and gene rearrangements are associated with a variety of tumor cell types.",fdaUniiCode:"K418KG2GET",identifier:"C115112",preferredName:a,semanticType:"Pharmacologic Substance",subclassOf:["C129825","C141136"],synonyms:["2,4-Pyrimidinediamine, 5-chloro-N4-(2-((1-methylethyl)sulfonyl)phenyl)-N2-(5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl)-","CERITINIB",a,"LDK 378","LDK378",c]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FCeritinib",extension:".json",createdAt:e,updatedAt:e}}],fetch:{},mutations:void 0}}("Ceritinib","ceritinib","Zykadia","","2021-10-30T13:18:55.593Z")));